Molecules, Vol. 25, Pages 3920: Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease
This article briefly reviews a series of studies on SARS-CoV, focusing on the development of inhibitors for the SARS-CoV 3CLpro based on molecular interactions with the 3CL protease. Our recent approach, based on the structure-based rational design of a novel scaffold for SARS-CoV 3CLpro inhibitor, is also included. The achievements summarized in this short review would be useful for the design of a variety of novel inhibitors for corona-viruses, including SARS-CoV-2.
Source: Molecules - Category: Chemistry Authors: Kenichi Akaji Hiroyuki Konno Tags: Review Source Type: research
More News: Chemistry | Coronavirus | COVID-19 | MERS | Middle East Health | Pandemics | Pneomococcal Vaccine | Pneumonia | Respiratory Medicine | SARS | Study | Vaccines